Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors

Summary

The purpose of this research study is to investigate the use of pelvic physical therapy for gynecologic cancer survivors who report sexual dysfunction. Physical therapy experts believe that a full 10-week regimen is necessary for true improvement of symptoms. Investigators aim to see if this tense regimen is feasible for survivors. Investigators also aim to see if patients have an improvement in their sexual function and quality of life.

Conditions

• Gynecologic Cancer
• Sexual Dysfunction

Interventions

OTHER

Control Arm

Participants randomized to this arm will only receive educational pamphlets with resources for sexual dysfunction and will not participate in physical therapy. Participants will be contacted at 3 months and 6 months to fill out two questionnaires about sexual function and quality of life. After 6months, if participants desire a referral to physical therapy, investigators will provide a referral.

OTHER

Physical Therapy Arm

Participants will receive a referral to begin a pelvic physical therapy regimen. Participants will complete the sexual function and quality of life questionnaires after completion of the physical therapy regimen and again 3 months after. There will be a brief exit interview.

OTHER

European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)

Questionnaire designed to measure cancer patients' physical, psychological and social functions

OTHER

Female Sexual Function Index (FSFI)

19-item self-report inventory designed to assess female sexual function.

OTHER

Exit Interview

11-item questionnaire for participants to give feedback to investigators about teir experience with the intervention.

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• Wake Forest University Health Sciences

  lead OTHER

Principal Investigators

• Suzanne K Danhauer, PhD · Wake Forest Baptist Comprehensive Cancer Center

• Anya Menzies, PhD · Wake Forest Baptist Comprehensive Cancer Center

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-03-28

Primary Completion

2022-09-14

Completion

2022-09-14

Countries

• United States

Study Locations